rs1019385 — GRIN2B

Promoter variant in the GRIN2B Sp1 binding site that reduces NR2B subunit expression, lowering NMDA receptor activity critical for learning and memory

See your personal result for GRIN2B

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

The Memory Gate: How Your GRIN2B Promoter Variant Shapes NMDA Receptor Expression

Your brain's ability to learn and form lasting memories depends on NMDA receptors11 NMDA receptors
N-methyl-D-aspartate receptors — ion channels that open when a neuron receives coincident signals, triggering the synaptic changes that underlie long-term potentiation (LTP) and memory consolidation. The NR2B subunit, encoded by GRIN2B, is the dominant regulatory subunit in the adult cortex and hippocampus — its expression level directly controls how strongly synapses can potentiate in response to experience. rs1019385 sits in the GRIN2B promoter at a transcription factor binding site, and your alleles at this position influence how much NR2B protein your neurons produce.

The Mechanism

The variant falls at position -200 relative to the GRIN2B transcription start site, within a binding site for Sp122 Sp1
Specificity protein 1 — a ubiquitous transcription factor that binds GC-rich promoter elements and recruits RNA polymerase to initiate gene expression. The original functional study by Miyatake et al.33 Miyatake et al.
Identification of a novel variant of the human NR2B gene promoter region and its possible association with schizophrenia. Mol Psychiatry, 2002 used luciferase reporter assays in PC12 cells and showed that the T allele (coded-strand notation; C on the genomic plus strand) drives significantly higher transcriptional activity than the G allele (A on the plus strand) in the presence of NGF — the growth factor that normally activates Sp1-dependent GRIN2B expression (P = 0.0013). The G/A allele disrupts this Sp1 site, reducing NGF-induced NR2B transcription.

The downstream consequence flows through NMDA receptor stoichiometry: NR2B-containing receptors have longer opening times and higher calcium permeability than NR2A-containing receptors, properties that favor induction of long-term potentiation. Lower NR2B expression produces receptors with a shorter integration window, making it harder for synapses to meet the coincidence-detection threshold needed for lasting plasticity.

The Evidence

The functional promoter data from Miyatake et al. 2002 (N=100 cases, 100 controls) established both the mechanistic role of the Sp1 site and a preliminary association with schizophrenia (G allele enriched in cases, P = 0.0164). While the case-control sample was small, the functional direction is consistent with the NR2B literature.

At the population genomic scale, Lee et al. 201844 Lee et al. 2018
Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals. Nature Genetics, 2018 identified 1,271 genome-wide significant loci for educational attainment, with enrichment in genes governing neuron-to-neuron communication — a category that prominently includes glutamate receptor subunits. Savage et al. 201855 Savage et al. 2018
Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence. Nature Genetics, 2018 identified 205 loci for intelligence, enriched in hippocampal pyramidal neurons and striatal medium spiny neurons — the cell types most dependent on NR2B-mediated plasticity.

Supporting the neurochemical angle, Gabbay et al. 200966 Gabbay et al. 2009
Glutamate receptor gene (GRIN2B) associated with reduced anterior cingulate glutamatergic concentration in pediatric OCD. Biol Psychiatry, 2009 found that rs1019385 was significantly associated with lower glutamatergic concentration in the anterior cingulate cortex in pediatric patients — a region central to cognitive control — directly linking this variant to a regional reduction in NMDA-mediated neurotransmission.

The key study for the supplement angle is Slutsky et al. 201077 Slutsky et al. 2010
Enhancement of learning and memory by elevating brain magnesium. Neuron, 2010, which showed that magnesium L-threonate (MgT) crosses the blood-brain barrier more efficiently than other magnesium salts, elevates brain magnesium to a degree that upregulates NR2B-containing NMDA receptors, enhances hippocampal LTP, and improves short-term, working, and long-term memory in rats. NR2B upregulation was a key part of the mechanism — making MgT particularly relevant for carriers with constitutively lower NR2B expression.

Practical Actions

For A-allele carriers — particularly AA homozygotes — the core strategy is to support NMDA receptor function from the input side. Magnesium L-threonate provides the most direct pharmacological lever: it raises brain magnesium, which in turn amplifies NMDA receptor responsiveness and upregulates NR2B expression. NMDA co-agonists glycine and D-serine are required for receptor opening (the glycine site must be occupied alongside glutamate); maintaining adequate dietary intake of these amino acids supports the fraction of NR2B receptors that do get expressed. Alcohol is a direct NMDA antagonist — it blocks the channel pore — so even moderate consumption compounds the functional deficit of lower NR2B expression and is especially worth minimizing for risk carriers.

Interactions

rs1019385 interacts functionally with rs3764028 (GRIN2B -421C/A) — a second promoter variant also studied in Alzheimer's disease and OCD cohorts, with independent effects on GRIN2B transcriptional activity. Carrying the A allele at both positions would compound the reduction in NR2B promoter activity. The chromatin-regulatory variant rs117578877 (studied by Bharadwaj et al. 2014 in a distal GRIN2B loop element) adds a third layer: that variant reduces GRIN2B mRNA in prefrontal cortex and impairs working memory, acting through a different regulatory mechanism but converging on the same NR2B expression endpoint.

Nutrient Interactions

magnesium increased_need
glycine increased_need
d-serine increased_need

Genotype Interpretations

What each possible genotype means for this variant.

CC Normal

Normal GRIN2B promoter activity

You carry two copies of the C allele at rs1019385 in the GRIN2B promoter. This allele maintains an intact Sp1 transcription factor binding site, supporting normal NGF-induced NR2B subunit expression in your cortex and hippocampus. About 33% of people globally share this genotype; it is most common in European and African populations.

AC Intermediate

One reduced-activity GRIN2B allele

The NR2B subunit is the limiting factor for long-term potentiation in adult cortex and hippocampus — longer channel opening times and higher calcium permeability relative to NR2A-containing receptors. Lower NR2B expression narrows the coincidence-detection window at each synapse, modestly raising the threshold for LTP induction. The effect in heterozygotes is partial and may be compensated by other regulatory mechanisms; functional deficits, if present, are likely subtle.

AA Reduced

Reduced GRIN2B promoter activity — lower NR2B expression

The functional data from Miyatake et al. 2002 (PMID 12476325) show that the G allele (plus-strand A at rs1019385) significantly reduces luciferase reporter activity driven by the GRIN2B promoter in NGF-stimulated PC12 cells, and that the G allele was overrepresented in schizophrenia cases versus controls (P = 0.0164). In a separate study, rs1019385 was associated with reduced anterior cingulate cortex glutamatergic concentration in pediatric OCD patients (Gabbay et al. 2009, PMID 19324536) — a regional biomarker consistent with diminished NMDA-mediated neurotransmission.

The NMDA receptor requires both a glutamate ligand and a co-agonist (glycine or D-serine) to open, and NR2B-containing heterodimers have uniquely slow closing kinetics that allow calcium entry and activation of the kinase cascades needed for synaptic strengthening. Reduced NR2B protein shifts the receptor population toward shorter-lived NR2A-containing complexes, raising the threshold for coincidence detection and LTP. The magnesium L-threonate data (Slutsky et al. 2010, PMID 20152124) are especially relevant: by raising brain magnesium, MgT upregulates NR2B expression — partially compensating for the promoter deficit — and demonstrably improves working memory and long-term memory in animal models.